000157414 001__ 157414
000157414 005__ 20240229123137.0
000157414 0247_ $$2doi$$a10.1016/j.dsx.2020.06.038
000157414 0247_ $$2pmid$$apmid:32755820
000157414 0247_ $$2ISSN$$a1871-4021
000157414 0247_ $$2ISSN$$a1878-0334
000157414 037__ $$aDKFZ-2020-01609
000157414 041__ $$aeng
000157414 082__ $$a610
000157414 1001_ $$0P:(DE-HGF)0$$ade Guia, Roldan M$$b0$$eLast author
000157414 245__ $$aStress, glucocorticoid signaling pathway, and metabolic disorders.
000157414 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2020
000157414 3367_ $$2DRIVER$$aarticle
000157414 3367_ $$2DataCite$$aOutput Types/Journal article
000157414 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1603112100_18279$$xReview Article
000157414 3367_ $$2BibTeX$$aARTICLE
000157414 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000157414 3367_ $$00$$2EndNote$$aJournal Article
000157414 500__ $$aDKFZ-ZMBH Alliance#LA:A170#
000157414 520__ $$aGlucocorticoids and the GR serve as an essential molecular mediator of stress and different physiologic processes. This review summarizes main findings from studies on the role of the GC/GR signaling in the modulation of genes for nutrient processing by the different organs involved in metabolic diseases.Descriptive review of relevant papers known to the author was conducted.Several high-throughput screenings in the past 15 years have identified potential GR DNA-binding regions in different cell types with genes that are annotated to be important for the control of metabolism. Transcriptional regulation of these GC-responsive genes provides links between the hypothalamic-pituitary-adrenal axis (HPA) and systemic energy homeostasis in both physiological and pathophysiological states. Future studies must reconsider the use of agonist, the utilization of animal models of stress and metabolic disorders, and validation in humans.This review recapitulates the significant role of the GC/GR signaling in molecular metabolic control and metabolic disorders. Potential future research focus and optimizations have also been identified.
000157414 536__ $$0G:(DE-HGF)POF3-311$$a311 - Signalling pathways, cell and tumor biology (POF3-311)$$cPOF3-311$$fPOF III$$x0
000157414 588__ $$aDataset connected to CrossRef, PubMed,
000157414 773__ $$0PERI:(DE-600)2273766-2$$a10.1016/j.dsx.2020.06.038$$gVol. 14, no. 5, p. 1273 - 1280$$n5$$p1273 - 1280$$tDiabetes & metabolic syndrome$$v14$$x1871-4021$$y2020
000157414 909CO $$ooai:inrepo02.dkfz.de:157414$$pVDB
000157414 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000157414 9131_ $$0G:(DE-HGF)POF3-311$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vSignalling pathways, cell and tumor biology$$x0
000157414 9141_ $$y2020
000157414 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-15
000157414 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-15
000157414 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-15
000157414 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2020-01-15
000157414 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-15
000157414 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-15
000157414 9202_ $$0I:(DE-He78)A170-20160331$$kA170$$lMolekulare Stoffwechselkontrolle$$x0
000157414 9201_ $$0I:(DE-He78)A170-20160331$$kA170$$lMolekulare Stoffwechselkontrolle$$x0
000157414 980__ $$ajournal
000157414 980__ $$aVDB
000157414 980__ $$aI:(DE-He78)A170-20160331
000157414 980__ $$aUNRESTRICTED